A prospective study of management of chemotherapy induced adverse event for breast cancer.
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000009855
- Lead Sponsor
- Showa University
- Brief Summary
Adverse events : No grade 3-4 myalgia, or peripheral sensory neuropathy was observed in either group. QoL : The time course of the mean QoL scores assessed using FACT-B, FACT-B TOI, and FACT-G. HRQoL were similar in both groups, with no significant differences.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 36
Not provided
Exclusion Criteria 1) Hypersensitivity of protocol therapy 2) Uncontrolled infection, diarrhea, bowel obstruction, diabetes, myocardinal infarction, heart failure, pulmonary fibrosis, pneumonitis, cerebrovascular disorder, other. 3) Active brain metastasis 4) Mental disorder 5) Severe myelosupression, renal and hepatic disfunction. 6) ascetic and pleural fluid 7) Pregnant, lactating or declined contraception 8) Patients considered ineligible by the attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method